Browsing Toxins
Displaying toxin 276 - 300 of 3678 in total
| T3DB ID | Name CAS Number | Formula Weight | Structure | Type | Mechanism of Toxicity |
|---|---|---|---|---|---|
| T3D2024 | 2,2',4,4',6-Pentabromobiphenyl 97038-97-6 | C12H5Br5 548.688 g/mol |  |
| The exact mechanism of toxicty of PBBs varies depending on the specific congener. The predominant interaction is believed to involve the aryl hydrocarbon receptor (AhR...more Number of Targets: 1 |
| T3D2021 | 2,3,4,4',5-Pentabromobiphenyl 96551-70-1 | C12H5Br5 548.688 g/mol |  |
| The exact mechanism of toxicty of PBBs varies depending on the specific congener. The predominant interaction is believed to involve the aryl hydrocarbon receptor (AhR...more Number of Targets: 1 |
| T3D2016 | 2,2',3,5',6-Pentabromobiphenyl 88700-05-4 | C12H5Br5 548.688 g/mol |  |
| The exact mechanism of toxicty of PBBs varies depending on the specific congener. The predominant interaction is believed to involve the aryl hydrocarbon receptor (AhR...more Number of Targets: 1 |
| T3D2014 | 2,3',4,4',6-Pentabromobiphenyl 86029-64-3 | C12H5Br5 548.688 g/mol |  |
| The exact mechanism of toxicty of PBBs varies depending on the specific congener. The predominant interaction is believed to involve the aryl hydrocarbon receptor (AhR...more Number of Targets: 1 |
| T3D2010 | 3,3',4,4',5-Pentabromobiphenyl 84303-46-8 | C12H5Br5 548.688 g/mol |  |
| The exact mechanism of toxicty of PBBs varies depending on the specific congener. The predominant interaction is believed to involve the aryl hydrocarbon receptor (AhR...more Number of Targets: 1 |
| T3D2004 | 3,3',4,5,5'-Pentabromobiphenyl 81902-33-2 | C12H5Br5 548.688 g/mol |  |
| The exact mechanism of toxicty of PBBs varies depending on the specific congener. The predominant interaction is believed to involve the aryl hydrocarbon receptor (AhR...more Number of Targets: 1 |
| T3D2003 | 2,2',4,4',5-Pentabromobiphenyl 81397-99-1 | C12H5Br5 548.688 g/mol |  |
| The exact mechanism of toxicty of PBBs varies depending on the specific congener. The predominant interaction is believed to involve the aryl hydrocarbon receptor (AhR...more Number of Targets: 1 |
| T3D2001 | 2,3',4,5,5'-Pentabromobiphenyl 80407-70-1 | C12H5Br5 548.688 g/mol |  |
| The exact mechanism of toxicty of PBBs varies depending on the specific congener. The predominant interaction is believed to involve the aryl hydrocarbon receptor (AhR...more Number of Targets: 1 |
| T3D2000 | 2,2',4,5,6'-Pentabromobiphenyl 80274-92-6 | C12H5Br5 548.688 g/mol |  |
| The exact mechanism of toxicty of PBBs varies depending on the specific congener. The predominant interaction is believed to involve the aryl hydrocarbon receptor (AhR...more Number of Targets: 1 |
| T3D1998 | 2,2',3,4,6-Pentabromobiphenyl 77910-04-4 | C12H5Br5 548.688 g/mol |  |
| The exact mechanism of toxicty of PBBs varies depending on the specific congener. The predominant interaction is believed to involve the aryl hydrocarbon receptor (AhR...more Number of Targets: 1 |
| T3D1995 | 2',3,4,4',5-Pentabromobiphenyl 74114-77-5 | C12H5Br5 548.688 g/mol |  |
| The exact mechanism of toxicty of PBBs varies depending on the specific congener. The predominant interaction is believed to involve the aryl hydrocarbon receptor (AhR...more Number of Targets: 1 |
| T3D1985 | 2,3',4,4',5-Pentabromobiphenyl 67888-97-5 | C12H5Br5 548.688 g/mol |  |
| The exact mechanism of toxicty of PBBs varies depending on the specific congener. The predominant interaction is believed to involve the aryl hydrocarbon receptor (AhR...more Number of Targets: 1 |
| T3D1984 | 2,2',4,5,5'-Pentabromobiphenyl 67888-96-4 | C12H5Br5 548.688 g/mol |  |
| The exact mechanism of toxicty of PBBs varies depending on the specific congener. The predominant interaction is believed to involve the aryl hydrocarbon receptor (AhR...more Number of Targets: 1 |
| T3D1969 | 2,2',4,5',6-Pentabromobiphenyl 59080-39-6 | C12H5Br5 548.688 g/mol |  |
| The exact mechanism of toxicty of PBBs varies depending on the specific congener. The predominant interaction is believed to involve the aryl hydrocarbon receptor (AhR...more Number of Targets: 1 |
| T3D1952 | 2,3,4,5,6-Pentabromobiphenyl 38421-62-4 | C12H5Br5 548.688 g/mol |  |
| The exact mechanism of toxicty of PBBs varies depending on the specific congener. The predominant interaction is believed to involve the aryl hydrocarbon receptor (AhR...more Number of Targets: 1 |
| T3D3556 | Ceric ammonium nitrate 16774-21-3 | CeH8N8O18 548.222 g/mol |  |
| Nitrate's toxicity is a result of it's conversion to nitrite once in the body. Nitrite causes the autocatalytic oxidation of oxyhemoglobin to hydrogen peroxide and met...more Number of Targets: 9 |
| T3D0717 | Lead chromate oxide 18454-12-1 | CrO5Pb2 546.400 g/mol |  |
| Lead mimics other biologically important metals, such as zinc, calcium, and iron, competing as cofactors for many of their respective enzymatic reactions. For example,...more Number of Targets: 34 |
| T3D0855 | Mirex 2385-85-5 | C10Cl12 545.543 g/mol |  |
| Mirex inhibits sodium/potassium-transporting ATPases, producing neurotoxic effects and impairing energy-dependent cellular processes. (A216) Number of Targets: 38 |
| T3D1803 | Tetrabromobisphenol A 79-94-7 | C15H12Br4O2 543.871 g/mol |  |
| Bromine is a powerful oxidizing agent and is able to release oxygen free radicals from the water in mucous membranes. These free radicals are also potent oxidizers and...more Number of Targets: 14 |
| T3D2953 | Doxorubicin 23214-92-8 | C27H29NO11 543.519 g/mol |  |
| Doxorubicin has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Doxorubicin forms complexes with DNA by intercalation between bas...more Number of Targets: 14 |
| T3D2791 | Epirubicin 56420-45-2 | C27H29NO11 543.519 g/mol |  |
| Epirubicin has antimitotic and cytotoxic activity. It inhibits nucleic acid (DNA and RNA) and protein synthesis through a number of proposed mechanisms of action: Epir...more Number of Targets: 3 |
| T3D3887 | Milbemectin (mixture) 51596-11-3 | C32H46O7 542.703 g/mol |  |
| Not Available Number of Targets: 23 |
| T3D1029 | Acrinathrin 101007-06-1 | C26H21F6NO5 541.439 g/mol |  |
| Both type I and type II pyrethroids exert their effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. They appear to bind to th...more Number of Targets: 19 |
| T3D3872 | Mancozeb 8018-01-07 | C8H12MnN4S8Zn 541.075 g/mol |  |
| Not Available Number of Targets: 82 |
| T3D3233 | CE(10:0) 1183-04-6 | C37H64O2 540.903 g/mol |  |
| Not Available Number of Targets: 2 |